Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Omnicom Group Inc. (OMC) vs Smith & Nephew plc (SNN) Price & Performance

Omnicom Group Inc.Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Omnicom Group Inc. vs Smith & Nephew plc — how do they compare? Omnicom Group Inc. trades at $78.55 (market cap $22.26B), while Smith & Nephew plc trades at $27.72 (market cap $11.63B). The key difference: Omnicom Group Inc. is the larger of the two by market cap, and Omnicom Group Inc. pays the higher dividend (3.94%). Which is the better fit depends on your goals.

OMCSNN
Market Cap
$22.26B$11.63B
Sector
MediaHealth
52-Week High
$88.94$38.53
52-Week Low
$67.27$27.80
Enterprise Value
$30.33B$14.66B
Dividend Yield
3.94%2.85%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Omnicom Group Inc.

Omnicom Group (OMC) trades at $81.13, down 1.8% on the day, with a bearish technical outlook and mixed quarterly earnings performance. The company reported strong revenue growth to $17.27 billion in 2025 but posted a net loss of $54.5 million due to acquisition costs. Analyst consensus remains cautious with a 'Hold' rating despite a $96.50 price target representing 19% upside potential. Recent leadership transitions and media agency consolidation signal strategic repositioning amid challenging market conditions.

OMC presents a value opportunity with attractive valuation multiples (P/S: 0.91x, P/B: 2.3x) and a 4% dividend yield, but faces integration risks from the Interpublic acquisition and margin pressure. The stock's near-term trajectory depends on successful cost synergies and organic growth acceleration beyond current 6.1% levels. Debt levels have increased substantially post-acquisition, requiring careful monitoring of cash flow generation.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $27.87, down 3.46% over 24 hours and near its 52-week low. The stock shows a bearish technical trend with mixed sentiment; recent earnings have mostly beaten expectations, but Q2 2026 revenue growth missed and guidance was cut. Fundamentals are solid with revenue rising to $6.16B in 2025 and net income margin improving to 10.08%, though debt levels have increased. The company faces competitive pressures in key markets like U.S. Orthopaedics.

Outlook is cautious: valuation ratios like P/E of 18.96 are reasonable, but analyst consensus is Hold (65%) due to execution risks and CFO departure. Opportunities include innovation in surgical robotics and new product launches, but investors should monitor U.S. market weakness and debt management for sustained recovery.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Omnicom Group Inc.

Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.

Read more on OMC

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN